Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: A report from the international rhabdomyosarcoma workshop

Medical and Pediatric Oncology

Volumn 19, Issue 2, 1991, Pages 89-95

  Rodary, Chantal ^a   Gehan, Edmund A ^c   Flamant, Françoise ^a   Treuner, JÖRn ^e   Carli, Modesto ^b   Auquier, Ariane ^a   Maurer, Harold ^d  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF TEXAS   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e OLGAHOSPITAL   (Germany)

Author keywords

Cox regression; predictors for survival time; RMS

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ADULT; ARTICLE; CANCER INVASION; CHILDHOOD; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOSARCOMA; STAGING; SURVIVAL; TUMOR LOCALIZATION;

CHILD; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMAN; LYMPH NODES; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; REGRESSION ANALYSIS; RHABDOMYOSARCOMA; SURVIVAL RATE; UROGENITAL NEOPLASMS;

EID: 0025906018     PISSN: 00981532     EISSN: 1096911X     Source Type: Journal    
DOI: 10.1002/mpo.2950190204     Document Type: Article

References (16)

1. An attempt to use a common staging system in rhabdomyosarcoma: A report of an International Workshop initiated by the International Society of Pediatric Oncology (sIOP)
2. Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study (iRS II)
3. Topography of childhood tumours: Pediatric Coding System
4. Primary chemotherapy in the treatment of rhabdomyosarcoma in children: Trial of the International Society of Pediatric Oncology (sIOP)—preliminary results
5. Results of the German rhabdomyosarcoma study (cWS‐81): Analysis according to the international agreement on common description of the tumor (paris, November, 1986)
6. Development of common criteria in childhood rhabdomyosarcoma
7. Design and analysis of randomized clinical trials requiring prolonged observation of each patient
8. Corrected group prognostic curves and summary statistics
9. Regression models and life tables
10. Rhabdomyosarcoma: The Stanford experience using a TNM staging system
11. Prognostic factors in 281 children with non‐Metastatic rhabdomyosarcoma at diagnosis
12. Extremity lesions in the Intergroup Rhabdomyosarcoma Study (iRS I)
13. Prognosis in children with rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Studies I and II